300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Africa
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Czech Republic
China
Armenia
Costa Rica
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Angola
Albania
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Europe
Cyprus
Mongolia
Spain
Qatar
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
ERP Startfonds, VC Fund

ERP Startfonds

VC Fund

Frankfurt, Germany

ERP Startfonds is a VC fund in Frankfurt focused on Biotechnology and Pharmaceutical. ERP Startfonds KfW finances and supports, among other things, business start-ups, small and medium-sized enterprises.

Total investments:
6
Last investment:
Lead investor:
17%

Last updated:

Industries ERP Startfonds invests in

BiotechnologyPharmaceuticalAppsMobileTravel

Stages ERP Startfonds invests in

Series BFunding RoundSeries A

Countries ERP Startfonds invests in

GermanyUnited States

Investment Focus

Industry

  • Biotechnology 3 (50%)
  • Pharmaceutical 2 (33%)
  • Apps 1 (17%)
  • Mobile 1 (17%)
  • Travel 1 (17%)
See all 11 industries →

Stage

  • Series B 2 (33%)
  • Funding Round 2 (33%)
  • Series A 1 (17%)

Country

  • Germany 4 (67%)
  • United States 1 (17%)

Investments

CompanyDescriptionRoundLinks
Rodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT’s patented TargoSphere® technology enables carrying a broad range of active agents selectively into the center of the immune response - i.e., directly into antigen-presenting cells.RBT currently applies its TargoSphere® technology successfullyin various models of infectious diseases caused by viruses like HCV/ Hepatitis C and HIV/ AIDS and by bacteria like in Tuberculosis, Legionellosis, and MRSA. Yet, any disorder that goes along with either overshooting or insufficient immunity caused by antigen-presenting cells - like chronic inflammations, cancers, allergies, and autoimmune diseases - may be addressed by RBT’s TargoSphere® technology. $2.9M / Apr 17, 2013
In 2009 founders Niclaus Mewes and Sven Kuelper launched "mytaxi" - the first taxi app with a direct connection between passenger and driver. mytaxi has grown to the fastest growing taxi-app with more than 7 million downloads and 35.000 connected taxis. mytaxi is available in over 40 German cities as well as Washington, Madrid, Barcelona,Warsaw, Vienna, Graz, Salzburg and Zurich. Investors include T-Venture Holding GmbH (Deutsche Telekom AG), Daimler Mobility Services GmbH (Daimler AG), KfW, e42 GmbH and Lars Hinrichs (Cinco Capital GmbH).mytaxi brings a demand for quality to the taxi service for the first time. Every driver using mytaxi has the ability to become a contractor and build their own client base by consistently providing passengers with good service and earning high customer ratings. Through the given peer-to-peer connection between passenger and driver the whole ordering process becomes very transparent for both. The passenger can not only track the taxi’s arrival in the app but also see which driver is coming. For the driver the cost modell is very attractive as they only pay for a successfully completed trip.The aim of mytaxi is to drive the concept of urban mobility and to further strengthen its position as an international leader in this field. Accordingly to that mytaxi took over the app development services for Daimler Mobility Services GmbH (Daimler AG). Series A / Jun 06, 2011
tolingo is one of the most renowned and successful translation agencies in Germany – a fact which motivates us in our work across every division of our company every day and helps drive us to constantly improve the services we offer to our clients. A human touch is crucial, whether in terms of our employees’ respectful, open interaction with oneanother at our headquarters in Hamburg, our consultations and service meetings with our clients, or the close, productive working relationships we enjoy with our specialist translators and industry experts all over the world. We strive for collaborative success and partnerships on equal footing without losing sight of the expectations we’ve set for ourselves or the standards and goals we’re determined to meet. This is how we’ve been able to transform from a little translation agency into a globally present provider with a sophisticated portfolio of services – with market-leader status in our sights. Series B / May 24, 2011
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases.Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application.However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases. $6.5M / Series A / May 17, 2011
m2p-labs was founded in November 2005 as a spin off of the department of biochemical engineering and the institute of materials in electrical engineering of the RWTH Aachen University. m2p-labs is a biotechnology company focused on the support of micro reaction solutions in biochemical engineering. The company offers a unique quantitative microreactor cultivation system which is applicable in high content screening and bioprocess development. $658K / Aug 11, 2008
caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner.caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, andisolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community. $8.8M / Series B / Jan 10, 2008

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Africa
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Czech Republic
China
Armenia
Costa Rica
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Angola
Albania
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Europe
Cyprus
Mongolia
Spain
Qatar
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does ERP Startfonds invest in?

ERP Startfonds invests primarily in Biotechnology, Pharmaceutical and Apps startups, most often at Series B and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did ERP Startfonds last invest?

The most recent investment recorded for ERP Startfonds closed in Apr 2013. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
ERP Startfonds ERP Startfonds Find emails